STEPHANIE BEAVER: Open Payments
NPI 1952052631 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 81 payments from 23 companies in 2025. Trend: 2023 $803 · 2024 $1,269 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $196 |
| PFIZER INC. | 10 | $195 |
| Otsuka America Pharmaceutical, Inc. | 6 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $116 |
| Biosense Webster, Inc. | 6 | $106 |
| Exact Sciences Corporation | 5 | $80 |
| Lilly USA, LLC | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Amgen Inc. | 4 | $60 |
Products named: REXULTI, Kerendia, CAPLYTA, CARTO 3, NURTEC ODT, VRAYLAR, MOUNJARO, PREVNAR 20.
Industry payments across AL — which companies pay providers there.
